The insulin receptor in South African families with lipo-atrophic diabetes mellitus DMA studies and variations in insulin binding, including the effect of pregnancy

South African Medical Journal

Volumn 87, Issue 9 SUPPL. 3, 1997, Pages 1277-1283

  Panz, Vanessa R ^a   Joffe, Barry I ^a   Raal, Frederick J ^a   Wing, Jeffrey R ^a   Kedda, Mary Ann ^a   Seftel, Harry C ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008269528     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Koller EA, Acilli D, Taylor SI. Mutations in the insulin receptor gene in insulin resistant patients. In: Weintraub BD, ed. Molecular Endocrinology. Basic Concepts and Clinical Observations. New York: Raven Press, 1994: 283-296.
2. Kriauciunas KM. Kahn CR, Muller-Wieland D, Reddy SSK. Taub R. Altered expression and function of the insulin receptor in a family with lipoatrophic diabetes. J Clin Endocrinol Metab 1988; 67: 1284-1293.
3. Magré J, Reynet C, Capeau J, Blivet M-J, Picard J. In vitro studies of insulin resistance in patients with lipoatrophic diabetes: Evidence for heterogeneous postbinding defects. Diabetes 1988; 37: 421-428.
4. Dörfler H, Wieczorek A, Wolfram G. Zöllner N. Binding of insulin to fibroblasts in lipoatrophic diabetes. Res Exp Med 1977; 170: 161-164.
5. Oseid S, Beck-Nielsen H, Pedersen O. Sovik O. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med 1977:296:245-248.
6. Rosenbtoom AL, Goldstein S, Yip CC. Normal insulin binding to cultured fibroblasts from patients with lipoatrophic diabetes. J Clin Endocrinol Metab 1977; 44: 803-806.
7. Wachslicht-Rodbard H. Muggeo M, Kahn CR, Saviolakis GA. Harrison LC, Flier JS. Heterogeneity of the insulin-receptor interaction in lipoatrophic diabetes. J Clin Endocrinol Metab 1981; 52: 416-425.
8. Lawrence RD. Lipodystrophy and hepatomegaly with diabetes, lipaemia and other metabolic disturbances. f.ancef 1946; 1: 724-741.
9. Berardinelli W. An undïagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol 1954; 14: 193-204.
10. Seip. M. Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? Acta Paediatr Scand 1959; 48: 555-574.
11. Taytor SI, Kadowaki T, Accili D, et aJ. Mutations in the insulin receptor gene in genetic forms of insulin resistance. Recent Prog Horm Res 1990; 46: 185-217.
12. Kadowaki T, Kadowaki M, Rechler MM, et aJ. Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. J Clin Invest 1990; 86:254-264.
13. Kusari J, Takata Y, Hatada E, Friedenberg G, Kolterman O, Olefsky JM. Insulin resistance and "diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor alleles. J Biol Chem 1991 ; 266: 5260-5267.
14. Pacini G, Bergman RN. Pacberg: an adaptive program for controlling the blood sugar. Comput Methods Programs Biomed 1983; 16: 13-20.
15. Bar RS, Gorden P, Roth J, Kahn CR, De Meyts P. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients. Effects of starvation, refeeding, and dieting. J Clin Invest 1976; 58: 1123-1135.
16. De Meyts P, Roth J. Cooperativity in ligand binding: a new graphic analysis. Biochem Biophys Res Commun 1975; 66: 1118-1126.
17. Munson PJ, Rodbard D. LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Anal Biochem 1980; 107: 220-239.
18. Sykes BC. DNA in heritable disease. Lancet 1983; 2: 787-788.
19. Seino S, Seino M, Bell Gl. Human insulin receptor gene: partial sequence and amplification of exons using the polymerase chain reaction. Diabetes 1990; 39: 123-128.
20. O'Rahilly S, Choi WH, Patel P, Turner RC, Flier JS, Moller DE. Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of singlestranded conformation polymorphisms. Diabetes 1991; 40: 777-782.
21. Joffe Bl, Segal I, Panz VR, Wing JR, Raal FJ, Seftel HC. Insulin resistance or insulin deficiency as precursor of non-insulin dependent diabetes mellitus. Lancet 1994;344: 1705.
22. O'Rahilly S, Hattersley A, Vaag A, Gray H. Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophecy? Lancet 1994; 344: 585-589.
23. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NtDDM? Diabetes 1994; 43: 735-739.
24. Catalano PM, Capeless EL, Simmons GM, Robbins DC, Norton ES. Successful pregnancy outcome in association with lipoatrophic diabetes mellitus. Obstet Cynecol 1990; 76: 978-979.
25. Steel JM, Johnstone FD, Hume R, Mao J-H. Insulin requirements during pregnancy in women with type I diabetes. Obstet Gynecol 1994; 83: 253-258.
26. Elbein SC, Sorensen LK. Genetic variation in insulin receptor β-chain exons among members of familial Type 2 (non-insulin-dependent) diabetic pedigrees. Diabetotogia 1991; 34: 742-749.
27. Krook A, Kumar S, Laing I, Boulton AJM, Wass JAH, O'Rahilly S. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 1994; 43: 357-368.
28. Panz VR, Ruff P, Joffe Bl, Kedda M-A, Seftel HC. SSCP analysis of the tyrosine kinase domain of the insulin receptor gene: polymorphisms detected in South African black and white subjects. Hum Genet 1996; 97: 438-440.
29. van der Vorm ER, Kuipers A, Bonenkamp JW. Patients with lipodystrophic. diabetes mellitus of the Seip-Berardinelli type, express normal insulin receptors. Diabetologia 1993; 36: 172-174.
30. Desbois-Mouthon C, Magré J, Amselem S, et al. Lipoatrophic diabetes: Genetic exclusion of the insulin receptor gene. J din Endocrinol Metab 1995; 80: 314-319.
31. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37: 907-925.
32. Auwerx J, Schoonjans K, Fruchart J-C, Staels B. Transcriptional control of triglycéride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-lll genes by activating the nuclear receptor PPAR. Atherosclerosis 1996; 124: suppl, 529-537.
33. Hitman GA, Hawrami K, McCarthy Ml, el al. Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease. Diabetologia 1995; 38: 481-486.
34. Panz VR, Wing JR, Raal FJ, Kedda M-A, Joffe Bl. Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis. Clinical Endocrinology 1997; 46: 365-368.